Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Jul 24, 2023

Total Value ($000): $257,667 (100.0% shares, 0.0% debt)

Holdings (7)

RVMD Revolution Medicines Inc 26.8%

Value ($000) $68,941 Shares 2,577,220 Est. Cost $34.24 Unrealized -28.4%

TNYA Tenaya Therapeutics, Inc. 21.4%

Value ($000) $55,180 Shares 9,400,290 Est. Cost $21.49 Unrealized -73.0%

— RAPT Therapeutics Inc 19.5%

Value ($000) $50,128 Shares 2,680,621 Est. Cost $19.03 Unrealized —

— NGM Biopharmaceuticals Inc 18.2%

Value ($000) $46,974 Shares 18,136,735 Est. Cost $27.77 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 10.7%

Value ($000) $27,689 Shares 3,568,181 Est. Cost $28.69 Unrealized -80.2%

— Surrozen, Inc. 2.0%

Value ($000) $5,178 Shares 9,414,795 Est. Cost $6.84 Unrealized —

— eFFECTOR Therapeutics Inc 1.4%

Value ($000) $3,578 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RVMD	Revolution Medicines Inc	2,577,220	$68,941	26.8%	$34.24	-28.4%	COM	76155X100
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$55,180	21.4%	$21.49	-73.0%	COM	87990A106
—	RAPT Therapeutics Inc	2,680,621	$50,128	19.5%	$19.03	—	COM	75382E109
—	NGM Biopharmaceuticals Inc	18,136,735	$46,974	18.2%	$27.77	—	COM	62921N105
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$27,689	10.7%	$28.69	-80.2%	COM	68622P109
—	Surrozen, Inc.	9,414,795	$5,178	2.0%	$6.84	—	COM	86889P109
—	eFFECTOR Therapeutics Inc	4,309,329	$3,578	1.4%	$14.05	—	COM	28202V108